Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04392323 · ClinicalTrials.gov registry record · NA

Incidence of COVID-19 Test Conversion in Post-surgical Patients

A NA study of Sars-CoV2, sponsored by Northwell Health.

Completed
Registry status
NA
Development phase
111
Enrollment target
2
Study locations

NCT04392323 is a NA study of Sars-CoV2 that has completed, run by Northwell Health. The registered enrollment target is 111 participants, below the 2,356-participant average among 5 other Sars-CoV2 trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04392323, a NA study of Sars-CoV2, has completed, sponsored by Northwell Health.

COMPLETED
Registry status
NA
Development phase
111 participants
Enrollment target
2
Study locations

Study Summary

The current Sars-CoV-2 (COVID-19) pandemic has created major changes in how physicians perform routine healthcare for our patients, including elective and non-elective surgical procedures. Beginning on March 16th, 2020 Northwell Health postponed all elective surgeries. As the incidence of COVID-19 cases begins to decrease and hospital volume improves we need to ensure the safety of our patients planning surgical procedures. However, at this time there is a scarcity of data regarding the COVID-19 test conversion rate in surgical patients. Our goal is to determine the COVID-19 test conversion rate in these patients to better guide strategies for restarting surgical care in a large-scale pandemic. Patients will be routinely tested with serology and PCR for COVID-19 24-48 hours prior to their scheduled surgery. Those who provide informed consent will be re-tested 12-16 days after discharge from the hospital to determine any potential nosocomial infection rate. Patients will also answer a few questions during their retest to allow the study team to gauge exposure risk postoperatively after leaving the hospital.

Conditions Studied

Sars-CoV2

Interventions

  • DIAGNOSTIC_TEST COVID-19 PCR and Serology

Study Locations (2)

New York

  • North Shore University Hospital - Manhasset
  • Long Island Jewish Medical Center - New Hyde Park

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2020-05-13
Est. Completion 2020-10-04
Phase NA

Sponsor

Northwell Health

370 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04392323

The ClinicalTrials.gov registry entry for NCT04392323 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,356-participant average among 5 other Sars-CoV2 trials with a reported enrollment target (95% lower). The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sars-CoV2 appearing as the primary indexed condition, and to 1 intervention - of which COVID-19 PCR and Serology is the first listed.

NCT04392323 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04392323 about?

NCT04392323 is a clinical study titled "Incidence of COVID-19 Test Conversion in Post-surgical Patients". The current Sars-CoV-2 (COVID-19) pandemic has created major changes in how physicians perform routine healthcare for our patients, including elective and non-elective surgical procedures. Beginning on March 16th, 2020 Northwell Health postponed all elective surgeries. As the incidence of COVID-19 c...

What is the current status of trial NCT04392323?

This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2020-05-13. Estimated completion is 2020-10-04.

What conditions does trial NCT04392323 study?

This clinical trial studies the following conditions: Sars-CoV2.

What interventions are being tested in trial NCT04392323?

The interventions under investigation include: COVID-19 PCR and Serology (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04392323?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04392323 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Sars-CoV2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Sars-CoV2

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.